Digiovanna Institute For Medical Education and Research

North Massapequa, New York 11758-1853

0 studies enrolling now · 11 studies all time

What they study most

ASCVD, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Clostridium Difficile (C. Difficile), Clostridium Difficile Infection, Crohn's Disease, Diarrhea, Migraine, Patients With Opioid Induced Constipation, Recurrent C. Difficile Infection

Studies at this site

• Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications — Completed
• Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) — Stopped early
• An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection — Status unconfirmed
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• Cardiovascular Inflammation Reduction Trial — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Study of CB-183,315 in Participants With Clostridium Difficile Infection — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Longitudinal Study of Patients With Opioid-Induced Constipation — Completed